Article

PODCAST: Dr. Goldfischer on OAB

PODCAST Efficacy and safety study comparing Oxybutynin 3% topical gel vs. placebo in adults with Overactive Bladder Syndrome.



PODCAST: Dr. Goldfischer on OAB

Efficacy and safety study comparing Oxybutynin 3% topical gel vs. placebo in adults with Overactive Bladder Syndrome.







Related Videos
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
DNA helix | Image Credit: © BillionPhotos.com - stock.adobe.com
Woman typing on laptop | Image Credit: © Gorodenkoff - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.